ANALYSIS OF GENETIC POLYMORPHISMS RELATED TO THROMBOSIS AND OTHER RISK-FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION

Citation
O. Salomon et al., ANALYSIS OF GENETIC POLYMORPHISMS RELATED TO THROMBOSIS AND OTHER RISK-FACTORS IN PATIENTS WITH RETINAL VEIN OCCLUSION, Blood coagulation & fibrinolysis, 9(7), 1998, pp. 617-622
Citations number
31
Categorie Soggetti
Hematology
ISSN journal
09575235
Volume
9
Issue
7
Year of publication
1998
Pages
617 - 622
Database
ISI
SICI code
0957-5235(1998)9:7<617:AOGPRT>2.0.ZU;2-B
Abstract
The purpose of this study was to investigate the role of genetic polym orphisms associated with venous and arterial thrombosis in patients wi th retinal vein occlusion (RVO). One-hundred and two consecutive patie nts with RVO were examined for factor V G1691A and factor II G20210A, methylenetetrahydrofolate reductase (MTHFR) C677T and apolipoprotein E -4 by amplification of specific DNA fragments and restriction analysis . The risks exerted by these polymorphisms and by the conventional ris k factors of RVO were evaluated by comparing their frequencies among p atients and controls and by estimating the respective odds ratios. We found that the prevalences of the factor V G1691A, factor ZI G20210A, and apolipoprotein E-4 polymorphisms were similar in the study and con trol groups. Logistic regression analysis involving the parameters far which significant differences were detected disclosed an odds ratio o f 1.9 for MTHFR C677T homozygosity (95% confidence interval 0.95-3.81) , an odds ratio of 2.12 for hypertension (95% confidence interval 1.16 -3.73) and an odds ratio of 3.25 for a family history of stroke (95% c onfidence interval 1.07-9.51). Our data suggests that homozygosity for the MTHFR C677T polymorphism is a risk factor of RVO in addition to a rterial hypertension and a family history of stroke. (C) 1998 Lippinco tt Williams & Wilkins.